1910 Genetics vs Desupervised

<p>1910 Genetics is an AI-driven software platform that transforms drug discovery by combining massive multimodal data, advanced AI models, and high-throughput laboratory automation. It targets scientists, researchers, and biotech companies aiming to innovate therapeutics effectively. By leveraging its proprietary ITO™ platform and PEGASUS™ AI model, you can speed up the development of breakthrough small and large molecule drugs, including macrocyclic peptides.</p> <p>With 1910 Genetics, you get a cohesive environment that supports collaboration, molecular design, and data integration tailored for AI-enabled discovery. You can also engage in co-engineering services to build customized drug discovery modules using interactive tools such as dashboards and chatbots. This platform is designed to push innovation boundaries in biotech, helping you get drugs to market faster with more precision and efficiency.</p>

<p>Desupervised is an AI-focused technology platform designed to make advanced analytics accessible to everyday users. It offers bespoke AI solutions tailored to your specific needs, empowering you to leverage state-of-the-art models for better, faster decision-making across many industries. Whether you need predictive insights into commercial activities or custom AI-driven workflows, Desupervised supports your goals.</p> <p>With products like Alviss, their predictive analytics platform, you gain real-time AI insights to drive your business forward. They also specialize in speeding up drug discovery through Bayesian Deep Virtual Screening, highlighting their strength in niche AI applications. Serving multiple markets since 2018 with over 2100 deployed models, Desupervised combines flexibility and expertise, making AI approaches practical and impactful for your operations.</p>